Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Eva Ellebæk, Trine Zeeberg Iversen, Niels Junker, et al.
Journal of Translational Medicine (2012) Vol. 10, Iss. 1
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Exploiting the curative potential of adoptive T‐cell therapy for cancer
Christian S. Hinrichs, Steven A. Rosenberg
Immunological Reviews (2013) Vol. 257, Iss. 1, pp. 56-71
Open Access | Times Cited: 449
Neoantigen landscape dynamics during human melanoma–T cell interactions
Els M.E. Verdegaal, Noel F.C.C. de Miranda, Marten Visser, et al.
Nature (2016) Vol. 536, Iss. 7614, pp. 91-95
Closed Access | Times Cited: 419
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss, Marco Donia, Katja Harbst, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 366
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan, Sofie Wilgenhof, John B.A.G. Haanen
Virchows Archiv (2018) Vol. 474, Iss. 4, pp. 449-461
Open Access | Times Cited: 346
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 23, pp. 2113-2125
Open Access | Times Cited: 317
Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
Sine Reker Hadrup, Marco Donia, Per thor Straten
Cancer Microenvironment (2012) Vol. 6, Iss. 2, pp. 123-133
Open Access | Times Cited: 290
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 24, pp. 2656-2666
Open Access | Times Cited: 274
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Rikke Andersen, Marco Donia, Eva Ellebæk, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 15, pp. 3734-3745
Open Access | Times Cited: 270
Pathways and therapeutic targets in melanoma
Emma Shtivelman, Michael A. Davies, Patrick Hwu, et al.
Oncotarget (2014) Vol. 5, Iss. 7, pp. 1701-1752
Open Access | Times Cited: 205
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U. Dafni, Olivier Michielin, Silvia Martin Lluesma, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1902-1913
Open Access | Times Cited: 202
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
Maartje W. Rohaan, Joost H. van den Berg, Pia Kvistborg, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 173
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
Shuhang Wang, Jingwei Sun, Kun Chen, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 152
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 99
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Kazemi, Maryam Sadri, Alireza Najafi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 89
TIL Therapy: Facts and Hopes
Tine Monberg, Troels Holz Borch, Inge Marie Svane, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3275-3283
Open Access | Times Cited: 49
Adoptive T cell therapy for solid tumors: current landscape and future challenges
Víctor Albarrán, María San Román, Javier Pozas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
Henrik Jespersen, Mattias F. Lindberg, Marco Donia, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 156
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 18, pp. 4416-4428
Open Access | Times Cited: 117
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Linh T. Nguyen, Samuel D. Saibil, Valentin Sotov, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 5, pp. 773-785
Open Access | Times Cited: 116
Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer
Marnix H. Geukes Foppen, Marco Donia, Inge Marie Svane, et al.
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1918-1935
Open Access | Times Cited: 115
Adoptive Cell Transfer for Patients with Metastatic Melanoma: The Potential and Promise of Cancer Immunotherapy
Giao Q. Phan, Steven A. Rosenberg
Cancer Control (2013) Vol. 20, Iss. 4, pp. 289-297
Open Access | Times Cited: 109
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
Clare Y. Slaney, Bianca von Scheidt, Alexander J. Davenport, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 10, pp. 2478-2490
Open Access | Times Cited: 109
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study
Magnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1502905-e1502905
Open Access | Times Cited: 103
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
Rikke Lyngaa, Natasja Wulff Pedersen, David Schrama, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 7, pp. 1768-1778
Open Access | Times Cited: 97
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
Nikolaj Pagh Kristensen, Christina Heeke, Siri Tvingsholm, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 2
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top